Premium
Everstone Capital is set to merge two of its healthcare portfolio companies, Translumina Therapeutics and Everlife Holdings, in preparation for an IPO, a media report said. The merged entity, combining India's leading cardiac stent maker with a Singapore-based distributor of medical devices and laboratory equipment, is expected to be valued at $1 ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
